Information:
Fel:
ID
34183
Beskrivning
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01975376
Länk
https://clinicaltrials.gov/show/NCT01975376
Nyckelord
Versioner (1)
- 2019-01-15 2019-01-15 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
15 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Cardiovascular Disease NCT01975376
Eligibility Cardiovascular Disease NCT01975376
- StudyEvent: Eligibility
Similar models
Eligibility Cardiovascular Disease NCT01975376
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
must be on background lipid lowering treatment.
boolean
ID.2
Item
must be at high risk of a cv event.
boolean
ID.3
Item
must have an ldl c >/=70 mg/dl (1.8 mmol/l) and < 100 mg/dl (2.6 mmol/l) or non-hdl-c >/= 100 mg/dl (2.6 mmol/l) and < 130 mg/dl (3.4 mmol/l).
boolean
ID.4
Item
an ldl c < 70 mg/dl (1.8 mmol/l) or >/= 100 mg/dl (2.6 mmol/l) or non hdl-c < 100 mg/dl (2.6 mmol/l) or >/=130 mg/dl (3.4 mmol/l).
boolean
ID.5
Item
planned coronary (pci or cabg) or other arterial revascularization.
boolean
ID.6
Item
new york heart association class iv congestive heart failure or left ventricular ejection fraction < 25% by cardiac imaging.
boolean
ID.7
Item
chronic renal insufficiency with creatinine clearance of <30 ml/min/1.73m^2 by mdrd formula or with end state renal disease on dialysis.
boolean
ID.8
Item
history of hemorrhagic stroke.
boolean
ID.9
Item
prior exposure to bococizumab or other investigational pcsk9 inhibitor.
boolean